About Bioassay
Bioassay is a company based in Heidelberg (Germany) founded in 2002 was acquired by Reaction Biology in December 2022.. The company has 53 employees as of December 31, 2021. Bioassay offers products and services including BioPharma Potency Assays, BioPharma Safety Assessments, Physico-Chemical Analysis, GLP Services, and Veterinary Product Testing. Bioassay operates in a competitive market with competitors including Ribometrix, ReNAgade, Creyon Bio, ArunA Bio and Avilar, among others.
- Headquarter Heidelberg, Germany
- Employees 53 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bioassay Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
53
as on Dec 31, 2021
-
Acquired by
Reaction Biology
(Dec 02, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bioassay
Bioassay offers a comprehensive portfolio of products and services, including BioPharma Potency Assays, BioPharma Safety Assessments, Physico-Chemical Analysis, GLP Services, and Veterinary Product Testing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develop and validate potency assays for biologics under GMP guidelines.
Conduct efficacy and safety studies for biosimilars and APIs.
Perform qualitative and quantitative analysis using HPLC equipment.
Provide toxicity and sensitization studies for compound selection.
Offer GMP potency testing for animal biologics and products.
Funding Insights of Bioassay
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Bioassay
Bioassay has secured backing from 1 investor. Prominent investors backing the company include Reaction Biology. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bioassay
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Bioassay
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bioassay Comparisons
Competitors of Bioassay
Bioassay operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ribometrix, ReNAgade, Creyon Bio, ArunA Bio and Avilar, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
RNA-targeted drug discovery platform using three-dimensional structural analysis is provided.
|
|
| domain | founded_year | HQ Location |
RNA-based medicines are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Oligonucleotide-based drug development platform is provided using AI models.
|
|
| domain | founded_year | HQ Location |
Neural exosome platform is developed for neurodegenerative disease therapeutics.
|
|
| domain | founded_year | HQ Location |
Drug discovery platform with protein degradation technology is provided.
|
|
| domain | founded_year | HQ Location |
AI-powered platform for drug discovery
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Bioassay
When was Bioassay founded?
Bioassay was founded in 2002.
Where is Bioassay located?
Bioassay is headquartered in Heidelberg, Germany. It is registered at Heidelberg, Baden-wurttemberg, Germany.
Who is the current CEO of Bioassay?
Sven Michael Cords is the current CEO of Bioassay.
How many employees does Bioassay have?
As of Dec 31, 2021, the latest employee count at Bioassay is 53.
What does Bioassay do?
Bioassay GmbH was established in 2002 in Heidelberg, Germany, within the biotechnology sector. Biological assays are developed and performed for quality control and product development in pharmaceuticals and chemicals. Emphasis is placed on areas including BioPharma Potency, Efficacy, Safety, and Safety assessments for Chemicals and Cosmetics. Operations adhere to GMP and GLP guidelines, with ISO certification maintained.
Who are the top competitors of Bioassay?
Bioassay's top competitors include Ribometrix, Creyon Bio and ArunA Bio.
What products or services does Bioassay offer?
Bioassay offers BioPharma Potency Assays, BioPharma Safety Assessments, Physico-Chemical Analysis, GLP Services, and Veterinary Product Testing.
Who are Bioassay's investors?
Bioassay has 1 investor. Key investors include Reaction Biology.